We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic Syndrome-Related Kidney Injury: A Review and Update.
- Authors
Lin, Lirong; Tan, Wei; Pan, Xianfeng; Tian, En; Wu, Zhifeng; Yang, Jurong
- Abstract
Metabolic syndrome (MetS) includes visceral obesity, hyperglycemia, dyslipidemia, and hypertension. The prevalence of MetS is 20-25%, which is an important risk factor for chronic kidney disease (CKD). MetS causes effects on renal pathophysiology, including glomerular hyperfiltration, RAAS, microalbuminuria, profibrotic factors and podocyte injury. This review compares several criteria of MetS and analyzes their differences. MetS and the pathogenesis of CKD includes insulin resistance, obesity, dyslipidemia, inflammation, oxidative stress, and endothelial dysfunction. The intervention of MetS-related renal damage is the focus of this article and includes controlling body weight, hypertension, hyperglycemia, and hyperlipidemia, requiring all components to meet the criteria. In addition, interventions such as endoplasmic reticulum stress, oxidative stress, gut microbiota, body metabolism, appetite inhibition, podocyte apoptosis, and mesenchymal stem cells are reviewed.
- Subjects
DISEASE risk factors; ENDOTHELIUM diseases; KIDNEY injuries; REGULATION of body weight; HYPERGLYCEMIA; METABOLIC syndrome; MESENCHYMAL stem cells
- Publication
Frontiers in Endocrinology, 2022, Vol 13, p1
- ISSN
1664-2392
- Publication type
Article
- DOI
10.3389/fendo.2022.904001